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Background. Little is known about effects of different bariatric surgery procedures on haemostatic 
and fibrinolytic parameters.
Material and methods. Consecutive obese subjects undergoing gastric bypass (GBP) or sleeve 
gastrectomy (SG) were enrolled. In all patients, levels of haemostatic factors (FII, FVII, FVIII, FIX, 
FX, vWF, fibrinogen), fibrinolytic variables (PAI-1, t-PA and D-dimer) and natural anticoagulants 
(AT, protein C and protein S) were evaluated before and 2 months after surgery.
Results. A total of 77 GBP and 79 SG subjects completed the study. At baseline no difference in 
coagulation parameters was found between the two groups. After both GBP and SG, subjects showed 
significant changes in haemostatic and fibrinolytic variables and in natural anticoagulant levels. The 
Δ% changes in FVII, FVIII, FIX, vWF, fibrinogen, D-dimer, protein C and protein S levels were 
significantly higher in subjects who underwent GBP than in those who underwent SG. Multivariate 
analysis confirmed that GBP was a predictor of higher Δ% changes in FVII (β=0.268, p=0.010), 
protein C (β=0.274, p=0.003) and protein S (β=0.297, p<0.001), but not in all the other variables. 
Following coagulation factor reduction, 31 subjects (25.9% of GBP and 13.9% of SG; p=0.044) 
showed overt FVII deficiency; protein C deficiency was reported by 34 subjects (32.5% of GBP vs 
11.4% of SG, p=0.033) and protein S deficiency by 39 (37.6% of GBP vs 12.6% of SG, p=0.009). 
Multivariate analyses showed that GBP was associated with an increased risk of deficiency of FVII 
(OR: 3.64; 95% CI: 1.73-7.64, p=0.001), protein C (OR: 4.319; 95% CI: 1.33-13.9, p=0.015) and 
protein S (OR: 5.50; 95% CI: 1.71-17.7, p=0.004). 
Discussion. GBP is associated with an increased risk of post-operative deficiency in some 
vitamin K-dependent coagulation factors. Whereas such deficiency is too weak to cause bleeding, it 
is significant enough to increase the risk of thrombosis. 
Keywords: obesity, haemostasis, fibrinolysis, bariatric surgery, natural anticoagulants.
Introduction
Severe obesity is one of the major health problems 
in western countries and is associated with several 
co-morbidities such as an increased incidence of 
cardiovascular disease1,2. In this respect, primary 
haemostasis (platelet function), fibrinolytic variables 
(tissue plasminogen activator [t-PA], plasminogen 
activator inhibitor-1 [PAI-1]) and secondary haemostatic 
factors (coagulation proteins; natural anticoagulants) 
are all known to play relevant roles in cardiovascular 
pathophysiology3. Impaired fibrinolysis and/or raised 
levels of coagulation factors and/or reduced levels of 
natural anticoagulants (protein C, protein S, antitrombin) 
have been recognized as major determinants of both 
arterial and venous thrombosis4. Several studies 
suggest that obesity is characterised by an increased 
expression of several prothrombotic factors, impaired 
fibrinolysis and platelet hyper-reactivity5. Weight loss 
has been found to (partially) revert both metabolic 
and vascular alterations found in obese subjects1. 
Besides nutritional and pharmacological treatments, an 
increasingly frequent management of severe obesity is 
bariatric surgery6. Based on their effect on food ingestion 
-reduction in stomach capacity or nutrient absorption- 
bariatric surgery has been classified as restrictive or 
malabsorptive, respectively. Although the efficacy 
of these surgical procedures in weight control and in 
improving metabolic impairments (e.g. remission of 
diabetes) has been widely described in several studies6-8, 
there is currently insufficient evidence to indicate 
how to assign a patient to a specific bariatric surgery 
procedure9. Moreover, although it is well known that 
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the risk of venous thromboembolic events is increased 
in patients undergoing bariatric surgery, little is known 
about the effects of different bariatric surgery techniques 
on haemostatic and fibrinolytic parameters. In this study 
we prospectively evaluated changes in haemostatic 
and fibrinolytic variables in obese subjects undergoing 
gastric bypass (GBP) or sleeve gastrectomy (SG). We 
also recorded changes in the levels of coagulation factors. 
Material and methods 
In a 36-month period (January 2009-January 2012), 
consecutive obese subjects referred to the Federico II 
University Hospital with an indication (according to 
the European Association for the Study of Obesity 
guidelines)9 for bariatric surgery were evaluated for 
enrolment in this study. In detail, a patient had to be 
admitted to undergo bariatric surgery following the 
failure of a non-surgical weight reduction programme 
including diet and other interventions (e.g., behavioural 
modifications, psychotherapy, dietary counselling, or 
physical training) and in the presence of a body mass 
index (BMI) >40 or >35 kg/m2 combined with serious 
co-existing conditions.
Only patients undergoing GBP or SG were included 
in the study. Exclusion criteria were indications for 
surgical procedures other than GBP or SG, known 
inherited bleeding disease, personal and/or family 
history of arterial or venous thrombosis, treatment with 
anticoagulant or antiplatelet drugs, other conditions 
known to affect haemostasis (liver disease, active 
inflammatory processes, pregnancy, malignancy, 
haematological diseases, puerperium, oral contraceptive 
intake and hormone replacement therapy), a history of 
chronic infectious disease (including hepatitis B and C) 
and unstable medical conditions. 
Before surgery (T0), information about age, gender, 
cardiovascular risk factors such as obesity, hypertension, 
impaired fasting glucose, hypercholesterolaemia, 
hypertriglyceridaemia and previous and/or current 
treatments were collected as described previously10. In 
addition, a venous blood sample was drawn from each 
patient. The sample was taken from the antecubital vein 
without venous stasis via a 19-gauge scalp-vein needle at 
8.30-9.00 a.m. after 12-15 hours of overnight fasting and 
collected into sterile tubes containing 2 mL sterile 3.8% 
trisodium citrate. The blood was then centrifuged at 3,000 
g for 15 minutes and the plasma processed immediately. 
Fibrinolytic variables (PAI-1, t-PA, PAI-1/t-PA ratio) and 
haemostatic variables (fibrinogen, D-dimer, coagulation 
factors II, VII, VIII, IX, X and von Willebrand factor 
[vWF], protein C, protein S and antithrombin) were 
determined.
PAI-1 and t-PA antigens (Imulyze™) were measured 
by enzyme-linked immunosorbent assays using kits 
from Biopool-Menarini (Florence, Italy)4. Fibrinogen 
activity was evaluated by the Clauss clotting method 
using a kit from Mascia Brunelli (Milan, Italy). Protein 
C activity was evaluated by a chromogenic method 
using a kit from Dade-Behring (Milan, Italy) whereas 
protein S antigen (Asserachrom®) was measured by 
enzyme-linked immunosorbent assay using a kit from 
Diagnostica Stago, Boehringer Mannheim (Milan, 
Italy)11. Levels of coagulation factor II, VII, VIII, IX, 
and X activity were determined by clotting assays (Dade-
Behring, Milan, Italy). vWF antigen was evaluated with 
a commercially available kit (INNOVANCE® VWF 
Ac Kit, Siemens Healthcare Diagnostics, Munich, 
Germany). Antithrombin activity was measured using 
a commercial kit (Berichrom ATIII, Behringwerke, 
Marburg, Germany)12. Levels of D-Dimer were assessed 
with the use of the INNOVANCE D-dimer kit (Siemens 
Healthcare Diagnostics). All laboratory measurements 
were performed by technicians unaware of the surgical 
procedure performed in each patient. 
All the operations were carried out by a team of 
expert surgeons, who had performed more than 500 
bariatric surgery procedures, and validated criteria were 
followed for the prevention of surgical site infection and 
perioperative antiplatelet drug administration13-15.
All clinical and laboratory evaluations reported 
above were repeated in all subjects 60 days (±10 
days) after surgery (T1). This time point was chosen 
to identify haemostatic changes occurring in the early 
post-operative period, while avoiding some potential 
confounding alterations due to the surgery-induced pro-
inflammatory and pro-thrombotic state.
The variability of the laboratory methods was 
assessed in samples collected twice within a 1-month 
period, in 260 subjects without any inflammatory, 
rheumatic or thrombotic disease, recruited in the same 
period of time from the hospital staff. All changes 
in laboratory parameters in study patients have been 
adjusted for the percentage of variability of the method 
found in the test group. 
This study was approved by the Local Ethics 
Committee of Federico II University.
Statistical analysis 
Statistical analyses were performed with the SPSS 
16 system (SPSS Inc., Chicago, IL, USA). Continuous 
data are expressed as means ± standard deviations (SD); 
categorical variables are expressed as percentages. To 
compare continuous variables, an independent sample 
t-test was performed. The Wilcoxon test for paired 
samples was employed as a non-parametric equivalent 
of the paired-samples t-test used for continuous 
variables. Abdominal obesity, hypertriglyceridaemia, 
hypercholesterolaemia, hypertension, diabetes and 
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smoking status were analysed as dichotomous (1/0) 
categories. The chi-square test was employed to analyse 
categorical data. When the minimum expected value 
was <5, Fisher's exact test was used. To adjust for all the 
other variables, multivariate analyses were performed 
with Δ% changes in haemostatic and fibrinolytic 
variables as dependent variables, and with age, gender, 
type of surgery (GBP vs SG), hypercholesterolaemia, 
hypertriglyceridaemia, diabetes, hypertension, smoking 
habit, obesity, baseline values of haemostatic and 
fibrinolytic parameters (FII, FVII, FVIII, FIX, FX, vWF, 
fibrinogen, D-dimer, antithrombin, protein C, protein S, 
PAI-1, t-PA) as independent variables. All the results 
are presented as two-tailed values and are considered 
statistically significant if the P values are less than 0.05.
In addition, logistic regression analyses, with the same 
independent variables as reported above, were used the 
determine the risk of deficiencies of haemostatic parameters. 
Sample size evaluation
With the aim of being as conservative as possible, 
planning a study with a sample size able to detect before-
after changes in haemostatic and fibrinolytic variables 
of more than 5% (±15 as standard deviation within 
the sampled population), at least 71 subjects for each 
surgical technique were needed to achieve a greater than 
80% power with a α error of 5%. 
Results 
Of the 213 subjects screened for inclusion in this 
study, 56 were excluded because of the presence of at 
least one exclusion criteria. In addition, one subject 
was excluded from the analysis because he was not re-
evaluated at the 2-month follow-up. Thus, a total of 156 
obese patients were enrolled in this study, 77 of whom 
underwent GBP and 79 who underwent SG. 
At baseline (T0) GBP and SG subjects were entirely 
comparable for all major clinical and demographic 
characteristics (Table I). In addition, all haemostatic 
and fibrinolytic variables were completely comparable 
between the two groups of subjects.
An increase in at least one of haemostatic or 
fibrinolytic parameter above higher normal levels 
-suggesting a hypercoagulable state- was found in 37 
(48.1%) GBP and 40 (50.6%) SG patients (p=0.752).  
All surgical procedures were performed without any 
significant peri-operative complications.  No infections 
or thrombotic complications were recorded. 
At the 2-month post-operative follow-up (T1), a 
21.3% reduction in BMI was found in the GBP group 
as compared with a 19.1% reduction in the SG group 
(p=0.139). In parallel, a reduction in haemostatic and 
fibrinolytic parameters was recorded in both the GBP 
and SG groups (Figure 1).
In detail, Δ% changes in the levels of FVII, FVIII, 
FIX, vWF, fibrinogen, and D-dimer were significantly 
greater in the GBP group than in SG group. In addition, 
GBP patients showed greater changes in protein C and 
protein S levels, as compared with those undergoing 
SG. In contrast, no differences were found in changes 
in antithrombin, FII, FX, PAI-1 and t-PA levels 
between patients undergoing the two different surgical 
procedures. 
Interestingly, Δ%BMI showed a direct correlation 
with Δ% changes in fibrinogen (r=0.386, p<0.001), 
FVIII (r=0.303, p<0.001), vWF (r=0.211, p=0.008) 
and PAI-1 (r=0.482, p<0.001), but not with any of 
the other haemostatic parameters. A direct correlation 
between Δ%PAI-1 and Δ%t-PA was also found (r=0.545, 
p<0.001).
Multivariate analysis showed that, after adjusting 
for major clinical and demographic characteristics 
(including BMI changes), GBP was consistently 
associated with greater Δ% changes in FVII (β=0.268, 
p=0.010), protein C (β=0.274, p=0.003) and protein S 
(β=0.297, p<0.001) levels, but not with any of the other 
variables. 
Table I  - Clinical and demographic characteristics of the 
study population before surgery.
Variable SG 
N=79
GBP 
N=77
p
Age (years) 37.9±3.1 38.7±3.9 0.186
Male gender 36 (45.6%) 45 (58.4%) 0.113
BMI 45.3±3.1 44.2±4.7 0.114
PAI-1 antigen 31.7±9.7 33.6±14.5 0.064
t-PA levels 4.8±1.8 5.4±2.0 0.061
Fibrinogen 315.8±48.2 314.1±81.9 0.867
D-dimer 228.8±232.3 211.9±121.3 0.573
FII 113.7±17.9 117.5±19.1 0.213
FVII 124.9±22.2 123.1±22.0 0.613
FVIII 124.6±20.6 123.5±23.4 0.745
FIX 133.9±25.5 132.9±24.2 0.814
FX 97.4±6.8 99.3±7.2 0.094
vWF 136.1±26.5 130.7±22.7 0.173
Protein C 116.7±18.3 118.8±15.4 0.441
Protein S 107.4±18.4 113.1±21.0 0.069
Antithrombin 97.9±6.2 99.7±7.15 0.096
Hypercholesterolaemia 47 (59.5%) 38 (49.4%) 0.206
Hypertriglyceridaemia 27 (34.2%) 25 (32.5) 0.866
Diabetes 39 (49.4) 38 (49.4) 1.000
Hypertension 37 (46.8%) 44 (57.1%) 0.205
Smoking habit 17 (21.5%) 22 (28.6%) 0.357
Obesity 79 (100%) 77 (100%) 1.000
All measurements were performed 1-3 days before surgery. 
SG: sleeve gastrectomy; GBP: gastric by-pass. 
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Interestingly, at the T1 assessment, 31 subjects 
(25.9% of GBP and 13.9% of SG patients, p=0.044) had 
FVII levels below lower normal cut-off values (i.e., they 
had FVII deficiency), whereas no deficiencies of any 
other clotting factor were found. In these 31 subjects 
with FVII deficiency, the mean FVII level was 54.5%
±8.44 (range, 39-69%).
As to natural anticoagulant levels, whereas no 
case of antithrombin deficiency was found, protein C 
deficiency was present in 34 subjects (32.5% of GBP 
patients vs 11.4% of SG patients, p=0.033) and protein 
S deficiency in 39 (37.6% of GBP patients vs 12.6% 
of SG patients, p=0.009). In the deficient subjects, the 
mean level of protein C was 57.4% ±4.58 (range, 50-
65%) and the mean level of protein S was 63.1% ±3.79 
(range, 58-69%). 
Separate multivariate analyses confirmed that GBP 
was associated with an increased risk of deficiency in 
FVII (odds ratio [OR]: 3.64; 95% confidence interval 
[CI]: 1.73-7.64; p=0.001), protein C (OR: 4.319; 95% 
CI: 1.33-13.9; p=0.015) and protein S (OR: 5.50; 95% 
CI: 1.71-17.7; p=0.004).
Discussion 
Results of this prospective study provide evidence 
about the effects of bariatric surgery on haemostatic 
and fibrinolytic balance. In detail, we documented that 
bariatric surgery is able to reduce the hypercoagulable 
state typical of obese subjects. Although both SG and 
GBP showed a clear efficacy in reducing levels of 
clotting factors and fibrinolytic variables, GBP was 
associated with greater reductions in FVII, protein 
C and protein S as compared with those following 
SG. However, these findings need to be discussed 
thoroughly. 
The total fibrinolytic potential of human blood 
is determined by the balance between plasminogen 
activators (t-PA) and plasminogen activator inhibitors 
(PAI-1)16. Increased PAI-1 levels are the expression of 
impaired fibrinolysis and, by inducing a pro-coagulant 
shift in the haemostatic balance, are associated 
with fibrin generation and, in turn, thrombosis17. 
Several studies have already documented impaired 
fibrinolysis in obese subjects and also demonstrated 
the effects of weight loss on reducing PAI-1 levels18. 
Our study, by showing a correlation between changes 
in BMI and in PAI-1 induced by bariatric surgery, 
confirmed and extended these data.
As to t-PA, the major activator of fibrinolysis, this 
has often been found to be increased in hypercoagulable 
states, in an attempt to counterbalance the thrombotic 
tendency4. Interestingly, in the present study we 
confirmed a direct correlation between post-operative 
Δ%PAI-1 and Δ%t-PA, further supporting this 
hypothesis.
Overall, our data showed that SG and GBP had similar 
efficacy in improving fibrinolytic balance, being associated 
with an approximately 20% reduction in PAI-1, which 
was accompanied by an approximately 10% reduction 
in t-PA.
Moving to the other haemostatic variables, compared 
to SG, GBP was associated with greater reductions in 
Figure 1 -  Δ% changes of haemostatic and fibrinolytic variables 2 months after sleeve gastrectomy 
(SG) or gastric bypass (GBP). 
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FVII, protein C and protein S levels. More in detail, 
changes in these three parameters seem to have different 
mechanisms and to exceed physiological changes. 
Indeed, besides weight loss-induced reductions, we 
also identified some cases of deficiency in these three 
haemostatic factors.
It is interesting to highlight that all three of these 
factors are vitamin K-dependent proteins. Vitamin K 
is one of the fat-soluble vitamins usually absorbed in 
the proximal small intestine by a saturable energy-
dependent process19. Two other vitamin K compounds 
(menaquinone and menadione) are absorbed by 
passive diffusion in the distal intestine and colon. As a 
consequence, pathological conditions in which there is 
malabsorption (e.g., Crohn's disease) may be associated 
with vitamin K deficiency19.
The risk of malabsorption and vitamin K deficiency 
after bariatric surgery is significant, being reported 
in to occur in 20% of patients after GBP20. Indeed, 
most of the malabsorptive bariatric procedures (such 
as GBP) involve surgical exclusion of a significant 
portion of bowel, usually including the proximal small 
intestine, which is one of the major sites of vitamin 
K absorption.
A lack of vitamin K can be associated with 
deficiencies in vitamin K-dependent clotting factors21. 
Although vitamin K-deficiency related changes in 
clotting factors have been thought to increase the 
risk of bleeding in patients who undergo bariatric 
surgery22, it is important to highlight that data derived 
from studies on major inherited bleeding disorders 
(haemophilia A and B, FVII deficiency)23,24 clearly 
indicate that mild deficiencies (clotting factor levels 
~40%) in FVII, FVIII and FIX are not associated with 
an increased risk of bleeding. Indeed, in haemophilia 
patients and in patients with FVII deficiency, bleeding 
manifestations usually occur when clotting factor 
levels are lower than 10%-20%. In our population, the 
31 patients with FVII deficiency had mean levels of 
approximately 50% and no unexpected perioperative 
bleeds were reported in our patients. Thus, although 
GBP is associated with a higher risk of acquired FVII 
deficiency, the bleeding risk should be marginal. 
However, further studies designed to address this 
issue are needed. 
Moving to natural anticoagulants the situation is 
totally different. Antithrombin, protein C and protein S 
are major compounds of the physiological anticoagulant 
system and their deficiencies are known to be severe 
risk factors for venous thromboembolism25. Indeed, 
some recent data clearly demonstrated that even a mild 
deficiency (factor levels 70-80%) of antithrombin, 
protein C or protein S  is associated with an increased 
risk of thrombosis12,26,27.
In the present study we have found a deficiency of 
protein C and protein S in 21.8% and 25% of patients, 
respectively. In contrast, no alterations in antithrombin 
levels were found. This is in line with the hypothesis 
of vitamin K deficiency-related alterations, since 
protein C and protein S are synthesised through vitamin 
K-dependent mechanisms, while the production of 
antithrombin is totally independent of this compound. 
Although vitamin K levels were not assessed in this 
study, the hypothesis of a vitamin K deficiency-
dependent mechanism is supported by the fact that 
deficiencies in protein C and protein S are more frequent 
in patients who undergo GBP, which is a malabsorptive 
procedure, than in those who undergo SG, which is 
a technique designed to preserve physiological gut 
absorptive function28. However, in line with previous 
studies showing that micronutrient deficiencies can also 
occur in patients undergoing restrictive procedures29,30, 
we also found some patients with clotting factor 
deficiencies in the SG group. This could be secondary to 
persistent vomiting and, in turn, to impaired absorption 
of macro- and micro-nutrients. 
Some limitations of this study should be discussed. 
Most of reported changes occurred in vitamin 
K-dependent factors and pre- and post-operative 
evaluation of vitamin K levels could have been useful 
to extend our findings. Although these data were 
not available for our patients, a previous study has 
already shown that the prolongation in activated partial 
thromboplastin time found in some patients undergoing 
bariatric surgery could be reverted by vitamin K 
administration31.    
Conclusion
In conclusion, our data suggest that although 
bariatric surgery is able to revert the hypercoagulable 
state usually reported in obese patients, in some cases, 
an acquired natural anticoagulant deficiency may occur 
and this could be associated with an increased risk of 
thrombosis32. Thus, changes in vitamin status and in 
haemostatic variables should be strictly monitored 
after bariatric surgery, particularly when malabsorptive 
procedures are used. 
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